SogoTrade Research Center








For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
Nektar Therapeutics
(NASDAQ: NKTR) Add to Portfolio
$22.48
-1.42 (-5.94%)
as of Jan 17, 2020

Last 22.48
Change -1.42 (-5.94%)
Open 23.87
Prev. Close 23.90
Today's Range
22.28 23.87
52wk Range
15.64 47.11
Volume 3,482,000
Avg Volume 3,233,790
Sector SIC-2834 Pharmaceutical Preparations

Recent Headlines
Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ: NKTR). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-652 (full story)
NKTR: 22.48 (-1.42)
Nektar Therapeutics (NASDAQ: NKTR) issued a statement today following a meeting of the Food and Drug Administration's (FDA's) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and Drug Safety and Risk Management A (full story)
: (), NKTR: 22.48 (-1.42)
SmarTrend identified an Uptrend for Nektar Therapeut (NASDAQ:NKTR) on November 11th, 2019 at $21.40. In approximately 2 months, Nektar Therapeut has returned 25.49% as of today's recent price of $26.86. (full story)
NKTR: 22.48 (-1.42)
InvestorsObserver issues critical PriceWatch Alerts for BILI, MSFT, NIO, NKTR, and NVDA. (full story)
BILI: 22.80 (-0.17), MSFT: 167.10 (+0.93), NKTR: 22.48 (-1.42), NIO: 4.67 (+0.30), NVDA: 249.28 (+0.35)
Shareholder rights law firm Robbins LLP reminds investors that purchasers of Nektar Therapeutics (NASDAQ: NKTR) filed a derivative complaint against the company's officers and directors for alleged breaches of their fiduciary duti (full story)
NKTR: 22.48 (-1.42)
 
Performance Comparison
Name Today 3-Month 1-Year
NKTR -5.94% +21.25% -50.51%
Growth Rates
YTD +4.15%
1-Year -51.34%
3-Year +87.02%
5-Year +53.76%
10-Year +96.85%
© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.